A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug market, revolutionizing diabetes and obesity treatment with its blockbuster ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated ...

Serena Williams, the tennis icon, has revealed her postpartum weight loss journey, shedding 31 pounds with the help of GLP-1 ...

Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...

Sales of the weight loss injection Wegovy have skyrocketed in the UK after the manufacturer of rival drug Mounjaro announced ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.

SIERRA Robichaud was among the first wave of people to see her excess fat melt away after starting weight loss jabs – and she ...

Certain batches of injectable medicines, including insulin and weight-loss drugs, were reported stolen in transit. Experts ...

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication ...

The regulator in its health alert letter mentioned that these stolen drugs are rDNA injectables that require strict ...